SIGYN THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
SIGYN THERAPEUTICS, INC. (SIGY) reported Adjustments to Additional Paid in Capital, Warrant Issued of $48.92 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-11-14
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $48.92K, a 72.69% decline year-over-year.
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $45.36K, a 54.48% decline year-over-year.
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $130.98K, a 17.12% increase year-over-year.
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $179.16K, a 29.93% decline year-over-year.
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $404.63K, a 52.86% decline from fiscal 2023.
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $858.28K, a 8.23% increase from fiscal 2022.
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $793.04K, a 321.67% increase from fiscal 2021.
- SIGYN THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $188.07K, a 15.88% decline from fiscal 2020.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-09-30 | $48.92K 10-Q · filed 2025-11-14 | $94.28K derived: sum of 2 quarters · filed 2025-11-14 | $225.26K derived: sum of 3 quarters · filed 2025-11-14 | |
| 2025-06-30 | $45.36K 10-Q · filed 2025-11-14 | $176.34K derived: sum of 2 quarters · filed 2025-11-14 | ||
| 2025-03-31 | $130.98K 10-Q · filed 2025-11-14 | |||
| 2024-12-31 | $404.63K 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $179.16K 10-Q · filed 2025-11-14 | $278.80K derived: sum of 2 quarters · filed 2025-11-14 | $390.64K derived: sum of 3 quarters · filed 2025-11-14 | |
| 2024-06-30 | $99.64K 10-Q · filed 2025-11-14 | $211.47K derived: sum of 2 quarters · filed 2025-11-14 | ||
| 2024-03-31 | $111.83K 10-Q · filed 2025-11-14 | |||
| 2023-12-31 | $858.28K 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $255.69K 10-Q · filed 2024-11-19 | |||
| 2023-03-31 | $578.02K 10-Q · filed 2024-11-19 | |||
| 2022-12-31 | $793.04K 10-K · filed 2024-02-20 | |||
| 2022-09-30 | $157.79K 10-Q · filed 2023-11-14 | $326.78K derived: sum of 2 quarters · filed 2023-11-14 | $489.14K derived: sum of 3 quarters · filed 2023-11-14 | |
| 2022-06-30 | $168.99K 10-Q · filed 2023-11-14 | $331.35K derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2022-03-31 | $162.36K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $188.07K 10-K · filed 2023-03-31 | |||
| 2021-06-30 | $34.12K 10-Q · filed 2022-11-14 | $148.03K derived: sum of 2 quarters · filed 2022-11-14 | $148.03K derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-03-31 | $113.91K 10-Q · filed 2022-11-14 | $113.91K derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 8-K/A 9 month · filed 2022-03-21 | $223.56K 10-K · filed 2022-03-21 | ||
| 2020-09-30 | $223.56K 8-K/A · filed 2020-12-30 |